Table 2.

(a) Location of the detected recurrence on [¹⁸F]PSMA-1007 PET and its relation to the treatment history in BCR patients (n = 28). Radiation therapy included ¹²⁵I-seed implantation therapy (n = 2). (b) Impact on patient management after [¹⁸F]PSMA-1007 PET in BCR patients

Treatment history	Number of patients
	Local recurrence	Metastasis
Radiation therapy (RT)	8/9 (88.9%)	1/9 (11.1%)
Radical prostatectomy	5/11 (45.5%)	4/11 (36.4%)
Radical prostatectomy and salvage RT	1/8 (12.5%)	7/8 (87.5%)

Impact on management	Number of patients
The treatment strategy was properly decided from PSMA-PET	22 / 28 (78.6%)
The decision by PSMA-PET was correct in patients treated with RT when evaluated from PSA response	11/11 (100%)